Contact
searchSearch
HMP Global
Login

Tenosynovial Giant Cell Tumor Excellence Forum

Tenosynovial Giant Cell Tumor
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.
Podcasts
Episode 4: Evolving Therapies for Ewing Sarcoma
10/15/2020
In the fourth episode, Brian Van Tine, MD, PhD, and Robert “Bob” Maki, MD, PhD, discuss recent trial data and evolving therapies for treatment of Ewing sarcoma.
In the fourth episode, Brian Van Tine, MD, PhD, and Robert “Bob” Maki, MD, PhD, discuss recent trial data and evolving therapies for treatment of Ewing sarcoma.
In the fourth episode, Brian Van...
10/15/2020
Oncology
Episode 3: Standard of Care Treatment for Ewing Sarcoma
Podcasts
Episode 3: Standard of Care Treatment for Ewing Sarcoma
09/24/2020
Brian Van Tine, MD, PhD, and Robert “Bob” Maki, MD, PhD, discuss recent data comparing the American Standard versus European Standard for treatment of Ewing sarcoma.
Brian Van Tine, MD, PhD, and Robert “Bob” Maki, MD, PhD, discuss recent data comparing the American Standard versus European Standard for treatment of Ewing sarcoma.
Brian Van Tine, MD, PhD, and...
09/24/2020
Oncology
Patients and Providers Share Insights on Safety, Use of Pexidartinib for TGCT
Videos
Patients and Providers Share Insights on Safety, Use of Pexidartinib for TGCT
06/05/2020
Claire Verschraegen, MD, discusses a study that examined the knowledge, attitudes, and behavior of patients and providers with regards to the safety and use of pexidartinib.
Claire Verschraegen, MD, discusses a study that examined the knowledge, attitudes, and behavior of patients and providers with regards to the safety and use of pexidartinib.
Claire Verschraegen, MD,...
06/05/2020
Oncology
Real-World Study Highlights Treatment, QOL Among US Patients With Diffuse-Type TGCT
Videos
Real-World Study Highlights Treatment, QOL Among US Patients With Diffuse-Type TGCT
05/27/2020
Claire Verschraegen, MD, comments on a real-world study examining the treatment and quality-of-life of patients with diffuse-type TGCT.
Claire Verschraegen, MD, comments on a real-world study examining the treatment and quality-of-life of patients with diffuse-type TGCT.
Claire Verschraegen, MD,...
05/27/2020
Oncology
Episode 2: Exploring the Territory of TGCT (Part 2)
Podcasts
Episode 2: Exploring the Territory of TGCT (Part 2)
05/06/2020
In this follow-up episode, Brian Van Tine, MD, PhD, and Robert “Bob” Maki, MD, PhD, continue to discuss how the diagnosis of and treatment landscape for TGCT has evolved in recent years.
In this follow-up episode, Brian Van Tine, MD, PhD, and Robert “Bob” Maki, MD, PhD, continue to discuss how the diagnosis of and treatment landscape for TGCT has evolved in recent years.
In this follow-up episode, Brian...
05/06/2020
Oncology
Episode 1: Exploring the Territory of TGCT (Part 1)
Podcasts
Episode 1: Exploring the Territory of TGCT (Part 1)
04/20/2020
In this inaugural episode, Brian Van Tine, MD, PhD, and Robert “Bob” Maki, MD, PhD, discuss the challenges of treating TGCTs and how the treatment landscape has evolved.
In this inaugural episode, Brian Van Tine, MD, PhD, and Robert “Bob” Maki, MD, PhD, discuss the challenges of treating TGCTs and how the treatment landscape has evolved.
In this inaugural episode, Brian...
04/20/2020
Oncology
Michiel van de Sande, MD, on a Multidisciplinary Approach to Treating TGCT
Podcasts
Michiel van de Sande, MD, on a Multidisciplinary Approach to Treating TGCT
03/30/2020
Dr van de Sande shares how TGCT therapy has evolved in the past 15 years, and walks through outcomes for surgery, RT, and pharmacotherapy.
Dr van de Sande shares how TGCT therapy has evolved in the past 15 years, and walks through outcomes for surgery, RT, and pharmacotherapy.
Dr van de Sande shares how TGCT...
03/30/2020
Oncology
Alternative Signaling Mechanisms in TGCT Could Improve Diagnosis, Treatment
Commentary
Alternative Signaling Mechanisms in TGCT Could Improve Diagnosis, Treatment
03/20/2020
Robert Maki, MD, PhD, comments on a study in which TGCTs were found to be characterized by variable alterations.
Robert Maki, MD, PhD, comments on a study in which TGCTs were found to be characterized by variable alterations.
Robert Maki, MD, PhD, comments...
03/20/2020
Oncology
TGCT Case Study Highlights Importance of Molecular Testing for Sarcomas
Commentary
TGCT Case Study Highlights Importance of Molecular Testing for Sarcomas
03/11/2020
Robert Maki, MD, PhD, comments on a case study and review of treatment options for patients with malignant TGCT.
Robert Maki, MD, PhD, comments on a case study and review of treatment options for patients with malignant TGCT.
Robert Maki, MD, PhD, comments...
03/11/2020
Oncology
Marilyn Bui, MD, PhD, Talks About TGCT and Diagnosis of the Disease
Interview
Marilyn Bui, MD, PhD, Talks About TGCT and Diagnosis of the Disease
02/10/2020
Dr Bui provides some insight on TGCT and how diagnosis of the disease has evolved thus far.
Dr Bui provides some insight on TGCT and how diagnosis of the disease has evolved thus far.
Dr Bui provides some insight on...
02/10/2020
Oncology

Section Editor

Robert Maki, MD, PhD
Northwell Health Cancer
Center Institute, New York

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use